The Valley Desk

NCT03443869 · Interventional trial

Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)

Overall registry status Completed

Phase 3

Conditions CMV Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov